These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11940253)

  • 1. Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation.
    Tabernero A; Schoonjans K; Jesel L; Carpusca I; Auwerx J; Andriantsitohaina R
    BMC Pharmacol; 2002 Apr; 2():10. PubMed ID: 11940253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate improves age-related endothelial dysfunction in rat resistance arteries.
    Alvarez de Sotomayor M; Mingorance C; Andriantsitohaina R
    Atherosclerosis; 2007 Jul; 193(1):112-20. PubMed ID: 16979646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells.
    Goya K; Sumitani S; Xu X; Kitamura T; Yamamoto H; Kurebayashi S; Saito H; Kouhara H; Kasayama S; Kawase I
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):658-63. PubMed ID: 14751809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment.
    Deplanque D; Gelé P; Pétrault O; Six I; Furman C; Bouly M; Nion S; Dupuis B; Leys D; Fruchart JC; Cecchelli R; Staels B; Duriez P; Bordet R
    J Neurosci; 2003 Jul; 23(15):6264-71. PubMed ID: 12867511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenofibrate improves vascular endothelial function and contractility in diabetic mice.
    Xu N; Wang Q; Jiang S; Wang Q; Hu W; Zhou S; Zhao L; Xie L; Chen J; Wellstein A; Lai EY
    Redox Biol; 2019 Jan; 20():87-97. PubMed ID: 30296701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity.
    Guerre-Millo M; Gervois P; Raspé E; Madsen L; Poulain P; Derudas B; Herbert JM; Winegar DA; Willson TM; Fruchart JC; Berge RK; Staels B
    J Biol Chem; 2000 Jun; 275(22):16638-42. PubMed ID: 10828060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate improves vascular endothelial function in diabetic mice.
    Xin R; An D; Li Y; Fu J; Huang F; Zhu Q
    Biomed Pharmacother; 2019 Apr; 112():108722. PubMed ID: 30970521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate.
    Gervois P; Kleemann R; Pilon A; Percevault F; Koenig W; Staels B; Kooistra T
    J Biol Chem; 2004 Apr; 279(16):16154-60. PubMed ID: 14764586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudy.
    Harmer JA; Keech AC; Veillard AS; Skilton MR; Marwick TH; Watts GF; Meredith IT; Celermajer DS;
    Atherosclerosis; 2015 Sep; 242(1):295-302. PubMed ID: 26233916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury.
    Yue TL; Bao W; Jucker BM; Gu JL; Romanic AM; Brown PJ; Cui J; Thudium DT; Boyce R; Burns-Kurtis CL; Mirabile RC; Aravindhan K; Ohlstein EH
    Circulation; 2003 Nov; 108(19):2393-9. PubMed ID: 14557369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice.
    Inoue H; Jiang XF; Katayama T; Osada S; Umesono K; Namura S
    Neurosci Lett; 2003 Dec; 352(3):203-6. PubMed ID: 14625020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenofibrate protects against acute myocardial I/R injury in rat by suppressing mitochondrial apoptosis as decreasing cleaved caspase-9 activation.
    Zhao Q; Cui Z; Zheng Y; Li Q; Xu C; Sheng X; Tao M; Xu H
    Cancer Biomark; 2017 Jul; 19(4):455-463. PubMed ID: 28582851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-alpha regulates postischemic liver injury.
    Okaya T; Lentsch AB
    Am J Physiol Gastrointest Liver Physiol; 2004 Apr; 286(4):G606-12. PubMed ID: 14615282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.
    Lalloyer F; Wouters K; Baron M; Caron S; Vallez E; Vanhoutte J; Baugé E; Shiri-Sverdlov R; Hofker M; Staels B; Tailleux A
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1573-9. PubMed ID: 21474829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular targets of fenofibrate in the cardiovascular-renal axis: A unifying perspective of its pleiotropic benefits.
    Balakumar P; Sambathkumar R; Mahadevan N; Muhsinah AB; Alsayari A; Venkateswaramurthy N; Dhanaraj SA
    Pharmacol Res; 2019 Jun; 144():132-141. PubMed ID: 30970278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate inhibits endothelin-1 expression by peroxisome proliferator-activated receptor α-dependent and independent mechanisms in human endothelial cells.
    Glineur C; Gross B; Neve B; Rommens C; Chew GT; Martin-Nizard F; Rodríguez-Pascual F; Lamas S; Watts GF; Staels B
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):621-8. PubMed ID: 23329136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate.
    Brouillette C; Bossé Y; Pérusse L; Gaudet D; Vohl MC
    J Hum Genet; 2004; 49(8):424-432. PubMed ID: 15249972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
    Kockx M; Gervois PP; Poulain P; Derudas B; Peters JM; Gonzalez FJ; Princen HM; Kooistra T; Staels B
    Blood; 1999 May; 93(9):2991-8. PubMed ID: 10216095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells.
    Lee H; Shi W; Tontonoz P; Wang S; Subbanagounder G; Hedrick CC; Hama S; Borromeo C; Evans RM; Berliner JA; Nagy L
    Circ Res; 2000 Sep; 87(6):516-21. PubMed ID: 10988245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenofibrate increases homocystinemia through a PPARalpha-mediated mechanism.
    Luc G; Jacob N; Bouly M; Fruchart JC; Staels B; Giral P
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):452-3. PubMed ID: 15076230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.